Back

European Respiratory Journal

44 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Therapeutic Response by Radiologic Pattern of Lung Injury in Myositis-Associated Interstitial Lung Disease: a Retrospective Cohort Study
2026-03-04 respiratory medicine 10.64898/2026.03.03.26347563
#1 (25.4%)
Show abstract

ObjectiveMyositis-associated interstitial lung disease (myositis-ILD) consists of two predominant radiologic patterns of lung injury--nonspecific interstitial pneumonia (NSIP) and organizing pneumonia (OP)--that oftentimes coexist. However, it remains unclear whether either is associated with clinical outcomes. We aimed to assess the therapeutic response in patients with NSIP-compared to those with OP-predominant myositis-ILD. MethodsThis retrospective, single-center cohort study recruited part...

2
Upper airway ciliary dysfunction in bronchiectasis: The EMBARC cilia cohort study
2026-02-04 respiratory medicine 10.64898/2026.02.03.26345362
#1 (23.1%)
Show abstract

Mucociliary clearance is a key component of the pathophysiology of bronchiectasis but cilia function is poorly defined. This study aims to characterize nasal ciliary function in bronchiectasis and examine associations with disease severity, infection, inflammation and outcome. Adults with bronchiectasis and healthy volunteers were recruited to the international observational study EMBARC-BRIDGE. Individuals with a known diagnosis of Primary Ciliary Dyskinesia (PCD) were excluded. Nasal respira...

3
Restriction with Normal Spirometry: A Retrospective Cohort Study
2025-12-16 respiratory medicine 10.64898/2025.12.15.25342141
#1 (19.4%)
Show abstract

BackgroundThough a normal forced vital capacity (FVC) is typically thought to imply the absence of restriction, recent data suggest that restriction may in fact be common among patients with normal spirometry. However, the clinical significance of restriction with normal spirometry is unknown. Research QuestionWhat clinical characteristics and outcomes are associated with restriction with normal spirometry? Study Design and MethodsWe interpreted pulmonary function tests (PFTs) with both static...

4
Baseline predictors of mortality in non-idiopathic pulmonary fibrosis interstitial lung disease - A retrospective cohort study at a tertiary centre in Malaysia
2026-02-15 respiratory medicine 10.64898/2026.02.12.26346139
#1 (19.3%)
Show abstract

Background and AimsThe prognosis of interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) has not been studied as extensively as IPF. This study aimed to evaluate baseline factors associated with mortality in non-IPF ILD, including demographic characteristics, respiratory function test (RFT), comorbidities, and ILD subtypes. MethodsThis retrospective cohort study analysed prospectively collected data of patients with non-IPF ILD at a single tertiary centre in Malaysia...

5
Serum Tumor Marker Profiles in Interstitial Lung Diseases: Implications for Differential Diagnosis and Disease Severity Assessment
2026-01-16 respiratory medicine 10.64898/2026.01.13.26344081
Top 0.1% (18.9%)
Show abstract

BackgroundInterstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated ILD (CTD-ILD), share similar features that complicate diagnosis. Tumor markers are often elevated in ILD, yet their diagnostic utility remains unclear. MethodsThis retrospective study included ILD patients hospitalized between 2018 and 2025. Serum levels of alpha-fetoprotein, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA125, CA153, neuron-specif...

6
Adult Life Course Trajectories of Lung Function and the Development of Interstitial Lung Abnormalities: The CARDIA Lung Study
2026-03-06 respiratory medicine 10.64898/2026.03.03.26347486
Top 0.1% (18.9%)
Show abstract

Background: Interstitial lung abnormalities (ILA) are radiologic findings of increased lung density or fibrosis in individuals without clinical interstitial lung disease (ILD) and are associated with increased mortality and progression to ILD. Understanding physiologic trajectories of lung function preceding ILA diagnosis may illuminate early mechanisms of lung injury. Methods: We recruited participants from the Coronary Artery Risk Development in Young Adults (CARDIA) Lung Study, a prospective ...

7
Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis
2025-12-19 respiratory medicine 10.64898/2025.12.18.25342312
Top 0.1% (18.6%)
Show abstract

Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are phenotypically divergent disorders arising from similar exposures (including cigarette smoke). Differences in DNA methylation may drive the exposed lung towards COPD vs. IPF. To characterize differential methylation in COPD and IPF lung tissue relative to controls, we conducted epigenome-wide association studies of COPD and IPF in lung tissue from the Lung Tissue Research Consortium (N=1029), adjusting for a...

8
Integrative multi-omic analyses identify major axes of heterogeneity in chronic obstructive pulmonary disease and uncover their molecular contributors
2026-01-24 respiratory medicine 10.64898/2026.01.22.26344654
Top 0.2% (18.2%)
Show abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating and progressive lung disease that affects millions of people worldwide. There is a continuing clinical need to characterize COPD at the molecular level to be able to identify the multi-omic biomarkers of its pathogenesis and to enable more accurate diagnoses and more effective treatment. We used Multi-Omics Factor Analysis (MOFA) to jointly analyze genomic, blood transcriptomic, and plasma proteomic data collected from 1,872 particip...

9
Respiratory and Gut Microbiota Correlate with Lung Function Recovery after Severe COVID-19
2026-02-10 respiratory medicine 10.64898/2026.02.09.26345630
Top 0.2% (17.9%)
Show abstract

RationaleSevere SARS-CoV-2 infection induces disrupted oropharyngeal and gut microbiota during acute disease which may persist and contribute to the development of post-acute pulmonary sequelae. To date, it is unclear whether dysbiosis following severe disease is linked to long-term pulmonary function impairment. ObjectivesTo determine associations between oropharyngeal and gut microbiota composition with lung function after severe COVID-19. Methods16S and internal transcribed spacer (ITS) rRN...

10
Efficacy and Safety of Sitafloxacin-Containing Regimen for Improved Treatment of Nontuberculous Mycobacterial Lung Disease: A Multi-Center Retrospective Study
2026-01-16 respiratory medicine 10.64898/2026.01.13.26343918
Top 0.2% (17.6%)
Show abstract

ObjectivesTo evaluate the efficacy and safety of sitafloxacin-containing regimens versus non-sitafloxacin therapy in patients with nontuberculous mycobacterial (NTM) pulmonary disease, focusing on sputum/BALF conversion rate, time of sputum/BALF culture conversion and radiographic improvement. MethodsThis retrospective cohort study analyzed 149 adults (76 control group vs. 73 sitafloxacin group) with NTM pulmonary disease treated between 2021 to 2024. Inclusion criteria: (1) Sitafloxacin group:...

11
Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and Relatives
2026-01-15 respiratory medicine 10.64898/2026.01.07.25342496
Top 0.2% (15.8%)
Show abstract

AbstractO_ST_ABSRationaleC_ST_ABSIdiopathic pulmonary fibrosis (IPF) is an age-related disorder with common and rare genetic risk factors. It is unknown if the effects of PF genetic risk factors differ by chronologic age. ObjectivesTo assess age-specific effects of genetic risk factors in PF patients and their relatives. MethodsWe identified common and rare genetic risk factors using a Columbia whole genome sequencing (WGS) cohort (777 IPF, 2905 controls) and replicated findings using Trans-Om...

12
Appraisal and extension of the ERS/ATS Interpretative Strategy for Pulmonary Diffusing Capacity.
2026-01-30 respiratory medicine 10.64898/2026.01.30.26345192
Top 0.2% (15.6%)
Show abstract

The ERS/ATS22 interpretative flowchart classifies diffusing capacity (DLco) into 5 scenarios with associated pathophysiology, and has not been tested on large patient groups. We aimed to obtain a more layered DLco interpretation, by interrogating DLco components Kco and VA, and by estimating lung inflation during the DLco test to identify the presence of restriction, which crucially impacts Kco interpretation. By assessing a "low VA" against lung inflation, a novel 9-scenario DLco classification...

13
Burden of Bronchiectasis Among COPD Patients in Bangladesh: Insights from a Cross-Sectional Study
2025-12-18 respiratory medicine 10.64898/2025.12.16.25342432
Top 0.3% (12.8%)
Show abstract

BackgroundBronchiectasis is an increasingly recognized structural complication among patients with chronic obstructive pulmonary disease (COPD), yet evidence from Bangladesh remains limited. This study aimed to determine the prevalence, clinical characteristics, radiological patterns, and associated factors of bronchiectasis among COPD patients in tertiary-level hospitals. MethodsA cross-sectional study was conducted among 129 COPD patients regardless of age distribution, all are met GOLD crite...

14
BMPR-II biomarkers for testing therapeutic efficacy in pulmonary arterial hypertension: The StratosPHere 1 study.
2025-12-20 respiratory medicine 10.64898/2025.12.19.25342649
Top 0.4% (12.4%)
Show abstract

Pulmonary arterial hypertension (PAH) is a rare, life-limiting disease where deficiency of the TGF/BMP pathways have causal roles in hereditary and idiopathic forms. It is an attractive candidate for therapeutic intervention but there is an unmet need for clinically-relevant and practical biomarkers that can measure target engagement. A major challenge has been the inaccessibility of lung tissue in disease for molecular profiling. Here we explore the surrogate capacity of peripheral blood BMP pa...

15
Single-Cell and TCR Profiling across Tissues Reveals GZMK⁺CD8⁺ T Cells as Drivers of Fibrosis in IPF
2025-12-22 respiratory medicine 10.64898/2025.12.20.25342718
Top 0.4% (12.2%)
Show abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with limited therapies and poorly defined cross-tissue immune mechanisms. We performed single-cell RNA sequencing and TCR profiling of paired lung, lymph node, and peripheral blood samples from patients with IPF, combined with functional coculture assays and mouse model. We identified GZMK-high CD8 T cells enriched in fibrotic lungs, displaying inflammatory but low-cytotoxic features. TCR and trajectory analyses indicated t...

16
Alveolar Immune Profiling Identifies Distinct Subphenotypes of Acute Respiratory Failure
2026-01-15 respiratory medicine 10.64898/2026.01.13.26344060
Top 0.4% (11.7%)
Show abstract

Acute respiratory failure causes millions of deaths worldwide each year, highlighting the need for a better understanding of its pathophysiology and approaches to identify treatment-responsive subphenotypes of patients. Although subphenotypes of acute respiratory failure have been described using peripheral blood biomarkers, it remains unclear whether lung-specific molecular profiles can define biologically and clinically meaningful subphenotypes. In this study, we identified four distinct subph...

17
Accuracy of Tuberculosis Infection Diagnosis through IP-10-Based Assays for Immune Detection of Present Mycobacterium tuberculosis: A Cross-Sectional Evaluation
2026-02-26 respiratory medicine 10.64898/2026.02.24.26346999
Top 0.4% (11.6%)
Show abstract

BackgroundReliable detection of latent Mycobacterium tuberculosis (Mtb) infection (LTBI) remains challenging, particularly in TB contacts and immunocompromised individuals, where interferon-{gamma} release assays (IGRAs) demonstrate variable sensitivity. IP-10, a chemokine produced at substantially higher concentrations than IFN-{gamma}, represents a promising immune marker. This study aimed to evaluate the diagnostic performance of two IP-10 based assays RIDA(R)QUICK TB (lateral flow) and RIDA...

18
Validation of the Hindi Version of the Bronchiectasis Health Questionnaire in a Hindi-speaking Indian population
2026-02-09 respiratory medicine 10.64898/2026.02.04.26345330
Top 0.4% (11.6%)
Show abstract

BackgroundBronchiectasis is a debilitating respiratory condition characterized by chronic cough with expectoration of thick sputum. It accounts for significant morbidity and mortality, especially when associated with exacerbations. Assessing the health-related quality of life (HR-QoL) of patients with bronchiectasis is important to ascertain the impact of the disease on day-to-day life, as well as to gauge the effect of targeted interventions. Conventionally used methods for assessing HR-QoL suc...

19
Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodies
2026-01-13 respiratory medicine 10.64898/2026.01.12.26343938
Top 0.5% (11.4%)
Show abstract

Community-acquired pneumonia is a major cause of morbidity and mortality globally. Specific molecular endotypes are currently not well defined and different viral or bacterial pathogens may trigger specific host responses and pathogenic mechanisms. We performed longitudinal proteomic profiling of bronchoalveolar lavage fluid and plasma from bacterial, influenza and SARS-COV-2 driven pneumonia. Our analysis revealed highly pneumonia type specific proteomic signatures, including COVID-19 specific ...

20
Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance
2026-01-02 respiratory medicine 10.64898/2025.12.28.25342520
Top 0.5% (11.1%)
Show abstract

Chronic infections in cystic fibrosis (CF) emerge from gradual ecological transitions in the airway microbiome, yet early predictive markers remain poorly defined. We developed a new autoencoder-based framework that outperforms read-based or metagenome-assembled genome-based analyses at capturing the continuum from health-associated commensals to pathogen-dominated, antibiotic-tolerant communities. This improvement is achieved by integrating taxonomic and functional data from 127 sputum and bron...